Other resolutive chemokines (RANTES/CCL5, MIP2/CXCL2, MDC/CCL22), and cytokines IL-1RA and IL-10 were quantified in SuperMApo (Supplementary Figure 5A) and thus added to recombinant TGF-β (all in similar quantity than measured in SuperMApo) to treat arthritis. This evidence concerns the gene CXCL2 and arthritic joint disease.